QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
NASDAQ:CLMT

Calumet Specialty Products Partners - CLMT Stock Forecast, Price & News

$16.27
-0.21 (-1.27%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$15.88
$16.54
50-Day Range
$8.64
$16.48
52-Week Range
$5.40
$17.43
Volume
193,514 shs
Average Volume
177,727 shs
Market Capitalization
$1.29 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.50

Calumet Specialty Products Partners MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
44.4% Upside
$23.50 Price Target
Short Interest
Healthy
0.69% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.04mentions of Calumet Specialty Products Partners in the last 14 days
Based on 14 Articles This Week
Insider Trading
Acquiring Shares
$415,170 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.01) to $1.42 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.43 out of 5 stars

Oils/Energy Sector

88th out of 261 stocks

Petroleum Refining Industry

11th out of 20 stocks

CLMT stock logo

About Calumet Specialty Products Partners (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. Its Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The company's Montana/Renewables segment focuses on processing renewable feedstocks into renewable hydrogen, renewable natural gas, renewable propane, renewable naphtha, renewable kerosene/aviation fuel, and renewable diesel. This segment also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. Its Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.

Calumet Specialty Products Partners Price Performance

Shares of NASDAQ:CLMT traded down $0.21 during midday trading on Monday, hitting $16.27. 193,514 shares of the company's stock were exchanged, compared to its average volume of 177,727. The stock's 50 day moving average price is $12.01 and its 200-day moving average price is $13.43. The firm has a market cap of $1.29 billion, a P/E ratio of -9.01 and a beta of 2.19. Calumet Specialty Products Partners has a twelve month low of $5.40 and a twelve month high of $17.43.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on CLMT. StockNews.com raised Calumet Specialty Products Partners from a "sell" rating to a "hold" rating in a report on Friday, May 13th. Cowen boosted their price objective on Calumet Specialty Products Partners from $18.00 to $20.00 and gave the company an "outperform" rating in a report on Tuesday, June 28th. Finally, Wells Fargo & Company boosted their price objective on Calumet Specialty Products Partners from $27.00 to $29.00 and gave the company an "overweight" rating in a report on Thursday, April 21st. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $23.50.

Insider Transactions at Calumet Specialty Products Partners

In other Calumet Specialty Products Partners news, Chairman Stephen P. Mawer acquired 9,251 shares of Calumet Specialty Products Partners stock in a transaction dated Friday, August 12th. The stock was acquired at an average cost of $16.11 per share, for a total transaction of $149,033.61. Following the completion of the transaction, the chairman now owns 137,233 shares in the company, valued at approximately $2,210,823.63. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, Chairman Stephen P. Mawer bought 9,251 shares of the business's stock in a transaction on Friday, August 12th. The stock was purchased at an average cost of $16.11 per share, for a total transaction of $149,033.61. Following the completion of the transaction, the chairman now directly owns 137,233 shares of the company's stock, valued at approximately $2,210,823.63. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Scott Obermeier bought 6,350 shares of the business's stock in a transaction on Tuesday, August 9th. The stock was purchased at an average price of $15.95 per share, with a total value of $101,282.50. Following the completion of the transaction, the executive vice president now directly owns 48,143 shares of the company's stock, valued at $767,880.85. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 25,852 shares of company stock worth $415,170. Company insiders own 2.91% of the company's stock.

Receive CLMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calumet Specialty Products Partners and its competitors with MarketBeat's FREE daily newsletter.

CLMT Stock News Headlines

Royal Purple® is a surprising way to save on gas
See More Headlines
Receive CLMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calumet Specialty Products Partners and its competitors with MarketBeat's FREE daily newsletter.

CLMT Company Calendar

Last Earnings
11/05/2021
Today
8/15/2022
Next Earnings (Estimated)
11/04/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Petroleum refining
Sub-Industry
N/A
Current Symbol
NASDAQ:CLMT
Employees
1,450
Year Founded
1916

Price Target and Rating

Average Stock Price Forecast
$23.50
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+44.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$-260,100,000.00
Pretax Margin
-3.39%

Debt

Sales & Book Value

Annual Sales
$3.15 billion
Book Value
($4.94) per share

Miscellaneous

Free Float
76,847,000
Market Cap
$1.29 billion
Optionable
Optionable
Beta
2.19

Social Links


Key Executives

  • Mr. Stephen P. Mawer (Age 57)
    Exec. Chairman of Calumet GP, LLC
    Comp: $1.29M
  • Mr. Louis Todd Borgmann (Age 39)
    CEO of Calumet GP, LLC
    Comp: $604.57k
  • Mr. Bruce A. Fleming (Age 65)
    Exec. VP of Montana Renewables & Corp. Devel. of Calumet GP, LLC
    Comp: $774.52k
  • Mr. Scott Obermeier (Age 49)
    Exec. VP of Specialty Products & Solutions of Calumet GP, LLC
    Comp: $611.96k
  • Mr. Vincent Donargo (Age 61)
    Exec. VP & CFO
  • Mr. Ryan A. Willman (Age 44)
    Chief Accounting Officer & Principal Accounting Officer of Calumet GP, LLC
  • Brad McMurray
    Director of Investor Relations
  • Mr. Marc Lawn (Age 49)
    Exec. VP of Performance Brands of Calumet GP, LLC
  • Mr. Chris Hodges
    Alpha IR













CLMT Stock - Frequently Asked Questions

Should I buy or sell Calumet Specialty Products Partners stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Calumet Specialty Products Partners in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CLMT shares.
View CLMT analyst ratings
or view top-rated stocks.

What is Calumet Specialty Products Partners' stock price forecast for 2022?

6 Wall Street research analysts have issued twelve-month price objectives for Calumet Specialty Products Partners' shares. Their CLMT share price forecasts range from $11.00 to $30.00. On average, they predict the company's share price to reach $23.50 in the next year. This suggests a possible upside of 44.4% from the stock's current price.
View analysts price targets for CLMT
or view top-rated stocks among Wall Street analysts.

How have CLMT shares performed in 2022?

Calumet Specialty Products Partners' stock was trading at $13.20 at the start of the year. Since then, CLMT shares have increased by 23.3% and is now trading at $16.27.
View the best growth stocks for 2022 here
.

When is Calumet Specialty Products Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our CLMT earnings forecast
.

How were Calumet Specialty Products Partners' earnings last quarter?

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) issued its earnings results on Friday, November, 5th. The oil and gas company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.79. The oil and gas company had revenue of $874.90 million for the quarter, compared to analysts' expectations of $864 million. During the same quarter last year, the business posted ($0.49) EPS.

What is Tim Go's approval rating as Calumet Specialty Products Partners' CEO?

18 employees have rated Calumet Specialty Products Partners Chief Executive Officer Tim Go on Glassdoor.com. Tim Go has an approval rating of 42% among the company's employees. This puts Tim Go in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Calumet Specialty Products Partners own?
What is Calumet Specialty Products Partners' stock symbol?

Calumet Specialty Products Partners trades on the NASDAQ under the ticker symbol "CLMT."

Who are Calumet Specialty Products Partners' major shareholders?

Calumet Specialty Products Partners' stock is owned by many different retail and institutional investors. Top institutional shareholders include Adams Asset Advisors LLC (6.86%), Knott David M Jr (5.46%), FMR LLC (1.09%), Barnett & Company Inc. (0.38%), LPL Financial LLC (0.18%) and Citadel Advisors LLC (0.00%). Insiders that own company stock include H Keith Jennings, Ryan Willman, Scott Obermeier and Stephen P Mawer.
View institutional ownership trends
.

How do I buy shares of Calumet Specialty Products Partners?

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Calumet Specialty Products Partners' stock price today?

One share of CLMT stock can currently be purchased for approximately $16.27.

How much money does Calumet Specialty Products Partners make?

Calumet Specialty Products Partners (NASDAQ:CLMT) has a market capitalization of $1.29 billion and generates $3.15 billion in revenue each year. The oil and gas company earns $-260,100,000.00 in net income (profit) each year or ($1.81) on an earnings per share basis.

How many employees does Calumet Specialty Products Partners have?

The company employs 1,450 workers across the globe.

Does Calumet Specialty Products Partners have any subsidiaries?
The following companies are subsidiares of Calumet Specialty Products Partners: Anchor Drilling Fluids USA, Bel-Ray, Bel-Ray Company LLC, Bel-Ray Company Pty Limited, Biosynthetic Technologies, Calumet Africa Proprietary Limited, Calumet Branded Products LLC, Calumet Cotton Valley Refining LLC, Calumet Dickinson Refining LLC, Calumet Finance Corp., Calumet International Inc., Calumet Karns City Refining LLC, Calumet Mexico LLC, Calumet Missouri LLC, Calumet Montana Refining LLC, Calumet Operating LLC, Calumet Princeton Refining LLC, Calumet Refining LLC, Calumet San Antonio Refining LLC, Calumet Shreveport Refining LLC, Calumet Specialty Oils de Mexico S. de R.L. de C.V., Calumet Specialty Products Canada ULC, Kurlin Company LLC, Montana Refining Company, Penreco, Royal Purple, Specialty Oil Field Solutions, TruSouth Oil, and United Petroleum Company.
Read More
When was Calumet Specialty Products Partners founded?

Calumet Specialty Products Partners was founded in 1916.

How can I contact Calumet Specialty Products Partners?

Calumet Specialty Products Partners' mailing address is 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214. The official website for the company is www.calumetspecialty.com. The oil and gas company can be reached via phone at (317) 328-5660, via email at investorrelations@clmt.com, or via fax at 317-328-2359.

This page (NASDAQ:CLMT) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.